GlassScriptPhysician profile
Steven S Roh
NPI 1750314795
$67,171.39
in general payments reported to CMS, 2019-2025
14 companies · $24K in 2025
The $24K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,721 · 2020: $3,437 · 2021: $5,682 · 2022: $3,248 · 2023: $7,526 · 2024: $18K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $46K · Food and Beverage: $2,930 · Travel and Lodging: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $46,100.00 |
| Food and Beverage | $2,929.87 |
| Travel and Lodging | $1,052.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $60,481.34 | 2019-2025 | Amplatzer Amulet, Amplatzer Talisman, Xience Skypoint |
| Medtronic, INC. | $2,115.90 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Tyrx |
| Boston Scientific Corporation | $1,826.69 | 2019-2025 | Versacross Access Solution, Watchman Flx, Eluvia |
| Medtronic Vascular, INC. | $1,768.44 | 2019-2020 | |
| Edwards Lifesciences Corporation | $334.49 | 2019-2025 | Sapien 3 Ultra Resilia |
| Inari Medical, INC. | $173.11 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $163.94 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $149.42 | 2019-2021 | |
| Terumo Medical Corporation | $58.66 | 2019-2023 | Angio-Seal, Glidesheath Slender |
| Cardiovascular Systems INC. | $32.06 | 2019 | |
| Bard Peripheral Vascular, INC. | $22.19 | 2025 | Rotarexs 6 F X 135 Cm |
| Cardiva Medical, INC. | $19.23 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Angiodynamics, INC. | $14.57 | 2021 | |
| Biotronik INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Roh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.